Stockholder’s Deficit (Details Narrative) - USD ($) |
1 Months Ended | 2 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 26, 2026 |
Jan. 26, 2026 |
Nov. 30, 2025 |
Aug. 09, 2025 |
Aug. 01, 2025 |
Jul. 16, 2025 |
Sep. 02, 2025 |
Jul. 25, 2025 |
Mar. 12, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Aug. 09, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Sep. 30, 2025 |
Jan. 04, 2026 |
Aug. 06, 2025 |
Aug. 05, 2025 |
Aug. 04, 2025 |
Jul. 14, 2025 |
May 22, 2025 |
Apr. 28, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | |||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||
| Common Stock, Shares Authorized | 150,000,000 | 150,000,000 | 150,000,000 | 150,000,000 | |||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||
| Common Stock, Shares, Outstanding | 20,347,137 | 20,347,137 | 11,000,000 | 14,521,094 | |||||||||||||||||||
| Common Stock, Shares, Issued | 200,000 | 20,347,137 | 20,347,137 | 11,000,000 | 14,521,094 | ||||||||||||||||||
| Class of Warrant or Right, Unissued | 6,900,000 | 6,900,000 | 6,900,000 | ||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||
| Sale of Stock, Price Per Share | $ 18.00 | $ 18.00 | $ 18.00 | $ 0.001 | |||||||||||||||||||
| Class of Warrant or Right, Outstanding | 8,396,069 | 8,396,069 | 7,304,992 | ||||||||||||||||||||
| Shares, Issued | 35,000 | 280,534 | |||||||||||||||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross | 500,000 | 6,350,000 | 6,350,000 | ||||||||||||||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period | 4 years | 4 years | 4 years | ||||||||||||||||||||
| General and Administrative Expense | $ 2,922,318 | $ 131,463 | $ 7,602,857 | $ 275,231 | $ 328,469 | $ 5,416,619 | |||||||||||||||||
| Share-Based Payment Arrangement, Noncash Expense | $ 1,167,311 | $ 2,841,166 | 250,000 | $ 2,636,283 | |||||||||||||||||||
| stock-based compensation | 31,128,519 | ||||||||||||||||||||||
| Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture | $ 30,000 | $ 60,000 | $ 500,000 | ||||||||||||||||||||
| Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture | 30,696 | 15,735 | |||||||||||||||||||||
| Restricted Stock Payable | $ 475,000 | $ 60,000 | |||||||||||||||||||||
| Employee Benefits and Share-Based Compensation | 143,221 | 0 | 188,221 | 0 | 0 | 30,000 | |||||||||||||||||
| Deferred Compensation Equity | $ 146,840 | 146,840 | 0 | 150,000 | |||||||||||||||||||
| Issuance Of Shares To Former Directors Description | On August 9, 2025, the Company entered into compensation agreements with three former directors, pursuant to which each director will receive $120,000 payable in cash or shares. Two directors elected to receive a total of $125,000 in shares and on September 10, 2025, total shares of 10,927 were issued. For the year ended September 30, 2025, total stock based compensation of $125,000 related to the compensation agreements with three former directors was included in general and administrative expense on the accompanying consolidated statements of operations. | On August 9, 2025, the Company entered into compensation agreements with three former directors, pursuant to which each director will receive $120,000 payable in cash or shares. Two directors elected to receive a total of $125,000 in shares and on September 10, 2025, total shares of 10,927 were issued and stock-based compensation of $125,000 related the compensation agreements with two former directors was included in general and administrative expense on the consolidated statements of operations during the year ended September 30, 2025. There was no issuance of shares for the three and six months ended March 31, 2026. | |||||||||||||||||||||
| Common Stock Fair Value Issued | $ 6,986,665 | $ 470,000 | $ 470,000 | ||||||||||||||||||||
| Stock Issued During Period, Shares, Issued for Services | 22,500 | ||||||||||||||||||||||
| Public Rights [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Convertible Preferred Stock, Shares Issued upon Conversion | 6,900,000 | ||||||||||||||||||||||
| Private Rights [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Convertible Preferred Stock, Shares Issued upon Conversion | 406,000 | ||||||||||||||||||||||
| Private Placement [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Class of Warrant or Right, Unissued | 406,000 | 406,000 | 406,000 | ||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 11.50 | $ 11.50 | $ 11.50 | ||||||||||||||||||||
| IPO [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Class of Warrant or Right, Unissued | 6,900,000 | 6,900,000 | 6,900,000 | ||||||||||||||||||||
| Board Of Directors [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 | |||||||||||||||||||||
| Shares, Issued | 7,000,000 | 7,000,000 | |||||||||||||||||||||
| Equity Option [Member] | |||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3.27 | $ 7.47 | $ 9.09 | $ 9.09 | $ 9.09 | $ 9.26 | $ 7.2 | ||||||||||||||||
| General and Administrative Expense | $ 1,119,097 | $ 0 | $ 3,128,944 | $ 0 | 0 | $ 511,847 | |||||||||||||||||
| Share-Based Payment Arrangement, Noncash Expense | $ 0 | $ 2,481,283 | |||||||||||||||||||||